Stay updated with breaking news from Nasdaq Bfri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biofrontera Inc. (NASDAQ:BFRI – Get Rating) saw a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 241,200 shares, a decline of 8.5% from the April 15th total of 263,700 shares. Approximately 1.6% of the shares of the stock are sold short. Based on an […]
Biofrontera (NASDAQ:BFRI – Get Rating) and Clever Leaves (NASDAQ:CLVR – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends. Volatility and Risk Biofrontera has a beta of 0.94, indicating […]
Biofrontera Inc. (NASDAQ:BFRI – Get Rating) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 263,900 shares, an increase of 20.1% from the March 15th total of 219,800 shares. Approximately 1.7% of the shares of the stock are short sold. Based on an […]
Biofrontera (NASDAQ:BFRI – Get Rating) and Clever Leaves (NASDAQ:CLVR – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends. Profitability This table compares Biofrontera and Clever Leaves’ net margins, […]
WOBURN, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...